Logo
Login
$UTHR
$591.35 -$1.49 (0.25%) Live

Company Executives

$UTHR Management Team

Dr. Martine Rothblatt

Chairman of the Board

Chief Executive Officer

Age 70
Compensation $23.01M USD
Sex Female

Mr. Michael Benkowitz

President

Chief Operating Officer

Age 53
Compensation $13.89M USD
Sex Male

Mr. Christopher Patusky

Lead Independent Vice Chairman of the Board

Age 61
Compensation $514.6K USD
Sex Male

Mr. James Edgemond

Chief Financial Officer

Treasurer

Age 58
Compensation $9.165M USD
Sex Male

Mr. Paul Mahon

Executive Vice President

General Counsel

Corporate Secretary

Age 61
Compensation $6.963M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 29, 2026
Directors
13
serving now
Independent
12 of 13
stated in the proxy
Average tenure
15.4 years
from year joined
CEO also chairs the board
Yes
Martine Rothblatt
Director Age On board Independent Committees Other public boards 2025 pay Source
Christopher Causey
63 2003
23 years
 Independent
Audit
None stated $508,034
Raymond Dwek
Not stated Not stated Independent None stated None stated $484,784
Richard Giltner
62 2009
17 years
 Independent
Audit · Chair Nominating and Governance
None stated Not stated
Ray Kurzweil
78 2002
24 years
 Independent None stated None stated Not stated
Jan Malcolm
70 2024
2 years
 Independent
Audit
None stated Not stated
Linda Maxwell
52 2020
6 years
 Independent
Compensation Nominating and Governance
ImmunityBio, Inc. $489,556
Nilda Mesa
66 2018
8 years
 Independent
Compensation Nominating and Governance
None stated Not stated
Judy Olian
74 2015
11 years
 Independent None stated Ares Management, Mattel, Inc. Not stated
Christopher Patusky
Lead independent director
 62 2002
24 years
 Independent
Compensation · Chair
None stated Not stated
Martine Rothblatt
Board chair, CEO
 71 1996
30 years
 Not independent None stated BETA Technologies, Inc. Paid as CEO
Louis Sullivan
92 2002
24 years
 Independent None stated None stated Not stated
Tommy Thompson
84 2010
16 years
 Independent None stated Healthpeak Properties, TherapeuticsMD, Inc. $483,034
Kevin Tracey
68 2026
0 years
 Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

3 disclosed in the proxy filed Apr 29, 2026
Jenesis Rothblatt
daughter of Dr. Rothblatt
Approximately $155,000
2025

Employment as Project Leader, Corporate Telepresence & Robotics, with total compensation

Open in proxy
company that is 50% owned by the son of our General Counsel
company 50% owned by the son of our General Counsel
$145,000
2025

Engagement of company to perform artificial intelligence-related services under an agreement

Open in proxy
son of our General Counsel
son of our General Counsel
$104,000
2025

Direct payments to the son of the General Counsel in connection with artificial intelligence services

Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans